share_log

Procter & Gamble Q3 earnings top estimates; raises FY22 top-line guidance

Benzinga Real-time News ·  Apr 20, 2022 09:23  · Earnings
  • $Procter & Gamble(PG.US)$ reported third-quarter FY22 sales growth of 7.1% year-on-year to $19.38 billion, beating the consensus of $18.73 billion.

  • Organic sales increased 10%, driven by a 3% increase in shipment volume, 5% from improved pricing, and a 2% increase from geographic and product mix.

  • Sales in the beauty segment rose 2%, the Grooming segment expanded 3%, and Health Care jumped 13%.

  • Adjusted EPS of $1.33 beat the consensus of $1.30.

  • Gross profit decreased 1% Y/Y to $9.1 billion. Gross margin decreased by 400 basis points to 46.7%.

  • Operating margin contracted 10 basis points to 20.8%, while operating income for the quarter rose 6% to $4.02 billion.

  • P&G held $8.5 billion in cash and equivalents as of March 31, 2022.

  • Outlook: P&G raised FY22 all-in sales growth outlook to 4% - 5% (previously 3% - 4%).

  • The company continues to expect FY22 core EPS growth of 3% - 6% versus FY21 Core EPS of $5.66.

  • P&G also expects to pay over $8 billion in dividends and repurchase $10 billion of common shares in FY22.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment